
Topme CH 50/12.5 Tablet ER
Marketer
Johnlee Pharmaceuticals Pvt Ltd
Salt Composition
Metoprolol Succinate (50mg) + Chlorthalidone (12.5mg)
Overview Topme CH 50/12.5 Tablet ER
Cardio-Control 50/12.5 Extended-Release tablets manage hypertension (high blood pressure). It's prescribed when a single medication proves insufficient. This treatment reduces the risk of future heart attacks and strokes, and early use significantly improves survival rates following a cardiac event. Take Cardio-Control 50/12.5 ER with or without food, ideally in the morning, to minimize nighttime urination. Continue taking it as directed, even if feeling well; untreated hypertension is often asymptomatic, and premature discontinuation can worsen your condition. Lifestyle modifications, including regular exercise, weight management, and a healthy diet, complement this therapy. Always follow your physician's instructions. Common side effects include nausea, constipation, diarrhea, and fatigue. Report any persistent, worsening, or bothersome side effects. Increase fluid intake to alleviate potential muscle weakness, dry mouth, or thirst. Initial dizziness or headache from lowered blood pressure usually subsides. Inform your doctor about pre-existing liver or kidney conditions, or if you are pregnant or breastfeeding. Disclose all other medications, particularly those for hypertension or heart disease. Regular monitoring of blood pressure, kidney function, blood sugar, and electrolyte levels (potassium and magnesium) is crucial to ensure therapeutic efficacy.
Uses of Topme CH 50/12.5 Tablet ER
Elevated blood pressure
Major Benefits of Topme CH 50/12.5 Tablet ER:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Topme CH 50/12.5 Extended-Release Tablet can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Topme CH 50/12.5 Tablet ER:
- Nausea
- Constipation
- Diarrhea
- Fatigue
- Headache
- Dizziness
- Slow heart rate
- Increased blood uric acid
- Decreased potassium level in blood
- Glucose intolerance
- Altered blood lipid level
- Cold extremities
- Decreased magnesium level in blood
- Increased calcium level in blood
How to use Topme CH 50/12.5 Tablet ER:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Topme CH 50/12.5 Extended-Release Tablets can be consumed with or without food, though consistent daily timing is recommended.
How Topme CH 50/12.5 Tablet ER works:
Topme CH 50/12.5 Extended-Release tablets combine metoprolol succinate, a beta-blocker, and chlorthalidone, a diuretic, to control hypertension. Metoprolol succinate acts on the heart, decreasing heart rate and improving its pumping efficiency. Chlorthalidone reduces blood pressure by promoting fluid and electrolyte excretion, and contributes to vasodilation and enhanced circulation over extended use.
SAFETY ADVICE
AlcoholUNSAFE
Combining Topme CH 50/12.5 Tablet ER and alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Extended-release Topme CH 50/12.5 tablets might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Extended-release Topme CH 50/12.5mg tablets are likely safe for breastfeeding mothers. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Extended-release Topme CH 50/12.5 tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Topme CH 50/12.5 Tablet ER, as dosage modification may be necessary. Medical advice is recommended. This medication is generally not advised for such individuals.
LiverCAUTION
Patients with hepatic impairment should use Topme CH 50/12.5 Tablet ER cautiously, potentially requiring dosage modification. Consult a physician before use. Topme CH 50/12.5 Tablet ER is contraindicated in individuals with severe liver dysfunction.
What if you forget to take Topme CH 50/12.5 Tablet ER :
Should you forget a Topme CH 50/12.5 Tablet ER dose, administer it immediately upon remembrance. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take more than the prescribed dose.
Facts to Know About Topme CH 50/12.5 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Heart |
